QEN Stock Overview
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
QEN passed our risk checks.
Centene Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$70.59 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.39 |
| 1 Month Change | -1.73% |
| 3 Month Change | 3.92% |
| 1 Year Change | 14.35% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -9.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| QEN | BG Healthcare | BG Market | |
|---|---|---|---|
| 7D | 1.3% | 1.0% | 0.5% |
| 1Y | 14.4% | -7.3% | 16.9% |
Return vs Industry: QEN exceeded the BG Healthcare industry which returned -5.8% over the past year.
Return vs Market: QEN underperformed the BG Market which returned 16.1% over the past year.
Price Volatility
| QEN volatility | |
|---|---|
| QEN Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in BG Market | 8.4% |
| 10% least volatile stocks in BG Market | 2.3% |
Stable Share Price: QEN has not had significant price volatility in the past 3 months.
Volatility Over Time: QEN's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 67,700 | Sarah London | www.centene.com |
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Centene Corporation Fundamentals Summary
| QEN fundamental statistics | |
|---|---|
| Market cap | €37.99b |
| Earnings (TTM) | €2.52b |
| Revenue (TTM) | €131.69b |
15.0x
P/E Ratio0.3x
P/S RatioIs QEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QEN income statement (TTM) | |
|---|---|
| Revenue | US$141.27b |
| Cost of Revenue | US$118.89b |
| Gross Profit | US$22.37b |
| Other Expenses | US$19.67b |
| Earnings | US$2.70b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 5.05 |
| Gross Margin | 15.84% |
| Net Profit Margin | 1.91% |
| Debt/Equity Ratio | 68.6% |
How did QEN perform over the long term?
See historical performance and comparison